Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 9/20 | 0.82 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.67 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.61 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.60 |
| ▸ | FAAH | O00519 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.55 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.55 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.55 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15846850 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL526043 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL543273 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL9830302 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL18038484 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL19049827 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL9830306 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL17204092 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL10829302 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH | |
| SCHEMBL3174181 | 1.00 | NOD1 (0.82) | NOD1PLA2G2CPLA2G10SLC6A5FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 383 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12290582-B2 | Creamy hydrating cosmetic composition in a water release emulsion | L'OREAL (FR) | 2025-05-06 | — | — | US | claimed |
| WO-2025043460-A1 | ANHYDROUS COMPOSITION FOR CARING FOR AND/OR MAKING UP KERATIN MATERIALS | L'OREAL (FR) | 2025-03-06 | — | — | WO | claimed |
| EP-4489868-A1 | COMPOSITION COMPRISING AT LEAST ONE AMPS® COPOLYMER, AT LEAST ONE ALKYL(POLY)GLYCOSIDE, AT LEAST ONE UV-SCREENING AGENT AND ISOPROPYL MYRISTATE | L'OREAL (FR) | 2025-01-15 | — | — | EP | claimed |
| EP-4452189-A1 | CREAMY HYDRATING COSMETIC COMPOSITION IN A WATER RELEASE EMULSION RELATED APPLICATIONS | L'OREAL (FR) | 2024-10-30 | — | — | EP | claimed |
| EP-3986364-B1 | COMPOSITION COMPRISING AT LEAST ONE AMPS® COPOLYMER, AT LEAST ONE ACYL GLUTAMIC ACID OR A SALT THEREOF AND AT LEAST ONE ALKYL POLYGLUCOSIDE | OREAL (FR) | 2024-10-16 | — | — | EP | claimed |
| CN-118593361-A | Surface treatment method for powder, surface treatment agent composition used therein, and surface-treated powder | 味之素株式会社 | 2024-09-06 | — | — | CN | claimed |
| CN-114423398-B | Surface treatment method for powder, surface treatment agent composition used therein, and surface-treated powder | 味之素株式会社 | 2024-07-16 | — | — | CN | claimed |
| CN-110291099-B | Synthesis of Liraglutide | 拜康有限公司 | 2024-06-21 | — | — | CN | claimed |
| CN-115645296-B | Cosmetic composition, preparation method and application thereof | 杭州唯铂莱生物科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| WO-2023229014-A1 | GELATION AGENT COMPOSITION | 味の素株式会社 | 2023-11-30 | — | — | WO | claimed |
| EP-2790785-A1 | COSMETIC COMPOSITION FOR COATING KERATIN FIBRES | L'Oréal (FR) | 2014-10-22 | — | — | EP | claimed |
| WO-2014060512-A1 | FATTY ACID ACYLATED AMINO ACIDS FOR GROWTH HORMONE DELIVERY | NOVO NORDISK HEALTH CARE AG (CH) | 2014-04-24 | — | — | WO | claimed |
| WO-2013087426-A1 | COSMETIC COMPOSITION FOR COATING KERATIN FIBRES | L'OREAL (FR) | 2013-06-20 | — | — | WO | claimed |
| US-20100278770-A1 | WAX-IN-WATER EMULSION COMPRISING A COMBINATION OF A GLUTAMIC ACID DERIVATIVE AND AN ALKYLPOLYGLYCOSIDE | L'OREAL (FR) | 2010-11-04 | — | — | US | claimed |
| EP-0473700-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1992-03-11 | — | — | EP | claimed |
| WO-1990014429-A1 | AN ENZYME-CATALYZED PROCESS FOR PREPARING N-ACYL AMINO ACIDS AND N-ACYL AMINO ACID AMIDES | NOVO NORDISK A/S (DK) | 1990-11-29 | — | — | WO | claimed |
| US-4749515-A | SULFOSUCCINIC ACID MONOESTERS, ACYLATED PEPTIDES; FOAMING, RINSING PROPERTIES | LION CORPORATION (JP) | 1988-06-07 | — | — | US | claimed |
| US-4075830-A | Solid adhesive compositions | KONISHI CO., LTD. (JA) | 1978-02-28 | — | — | US | claimed |
| US-4028480-A | FERROUS CARBOXYLIC ACID SALT | SOCIETE CHIMIQUE DES CHARBONNAGES - CDF CHIMIE (FR) | 1977-06-07 | — | — | US | claimed |
| US-3971701-A | FATTY ACID, ESTER OR N-ACYLAMINO ACID SURFACTANT | AJINOMOTO CO., INC. (JA) | 1976-07-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100278770-A1 | WAX-IN-WATER EMULSION COMPRISING A COMBINATION OF A GLUTAMIC ACID DERIVATIVE AND AN ALKYLPOLYGLYCOSIDE | KRT18, GRIK5, GRIK2 | NOD1 4832/4885PLA2G2C 1322/4885PLA2G10 1314/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.